Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02709512
Title Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (ATOMIC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Polaris Group
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | AUS

No variant requirements are available.